Male Hypogonadism – Current Treatment – Treatment Algorithms: Claims Data Analysis – Male Hypogonadism (US)
Male hypogonadism (low testosterone, or low T) is a condition characterized by impaired spermatogenesis and low serum testosterone. Most cases are secondary, driven by aging or comorbidities (e.g., obesity). TRT is the primary treatment, aiming to restore physiologic testosterone levels, and is typically delivered through injections, oral formulations, or topical products. Oral testosterone undecanoate options such as Jatenzo, Tlando, and Kyzatrex offer an alternative that avoids the injection-site reactions associated with intramuscular testosterone. However, a key drawback of TRT is suppressed spermatogenesis, and some alternative therapies focus on stimulating endogenous gonadotropins to preserve fertility. This analysis reviews U.S. physician prescribing patterns using patientlevel claims data.
Questions answered
- What patient shares do key therapies and brands garner by line of therapy in newly diagnosed low T patients? What are the quarterly trends in prescribing among recently treated and newly diagnosed low T patients?
- How have testosterone cypionate injection, testosterone enanthate injection, testosterone gel, testosterone undecanoate, and others been integrated into the treatment algorithm, and what is their source of business?
- What percentage of low T patients receive drug therapy within one year of diagnosis, and how quickly? What percentage of patients progress to later lines of therapy within one year of diagnosis?
- What percentage of low T patients are treated with monotherapy vs. combination therapy? What are the most commonly used combinations?
- What are the product-level compliance and persistency rates among drug-treated patients?
Geography: United States
Key drugs covered: Jatenzo, Kyzatrex, Tlando, Xyosted
Key analyses
- Brand / therapy usage across longitudinal patient sample
- Newly diagnosed patient analysis
- Treatment initiation and progression
- Line of therapy analysis
- Combination therapy analysis
- Source of business for recently treated patients
- Persistency and compliance analysis
Product description
Treatment Algorithms: Claims Data Analysis provides detailed, quantitative analysis of the treatment journey and brand usage across lines of therapy and overall using real-world, patient-level claims data, enabling you to:
- Understand patient flow between lines of therapy.
- Evaluate your brand share against competitors.
- Accurately assess your source of business.
- Quantify opportunities at different stages of the treatment algorithm.
Product enhancement
Treatment Algorithms: Claims Data Analysis leverages Clarivate’s proprietary Real-World Data, which brings larger patient samples, broader payer coverage, and faster availability for more robust and timely analyses. Additionally, we include new patient demographic analyses: age, gender, ethnicity, and region.
